HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

Christian Reinhard Mayr; Tobias Kiesslich; S Erber; Dino Bekric; Heidemarie Dobias; Markus Ritter; Tarkan Jäger; null Neumayer; Eckhard Klieser; Daniel Neureiter

HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

Christian Reinhard Mayr, Tobias Kiesslich, S Erber, Dino Bekric, Heidemarie Dobias, Markus Ritter, Tarkan Jäger, Neumayer, Eckhard Klieser, Daniel Neureiter

Publikation: Konferenzbeitrag › Poster

Originalsprache	undefiniert/unbekannt
Publikationsstatus	Veröffentlicht - 2021
Veranstaltung	Cholangiocarcinoma Foundation (CCF) Annual Conference 2021 - Herriman, Utah (virtuell), USA/Vereinigte Staaten Dauer: 31 März 2021 → 2 Apr. 2021

Konferenz mit wissenschaftlichem Inhalt

Konferenz mit wissenschaftlichem Inhalt	Cholangiocarcinoma Foundation (CCF) Annual Conference 2021
Land/Gebiet	USA/Vereinigte Staaten
Ort	Herriman, Utah (virtuell)
Zeitraum	31/03/21 → 2/04/21

1 Abstrakt

HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.
Mayr, C. R., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Ritter, M., Jäger, T., Neumayer, Klieser, E. & Neureiter, D., 2021.
Publikation: Konferenzbeitrag › Abstrakt

Dieses zitieren

Mayr, C. R., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Ritter, M., Jäger, T., Neumayer, Klieser, E., & Neureiter, D. (2021). HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.. Postersitzung präsentiert bei Cholangiocarcinoma Foundation (CCF) Annual Conference 2021, Herriman, Utah (virtuell), USA/Vereinigte Staaten.

@conference{eef7c6ddcfb044348491b70429d61364,

title = "HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.",

author = "Mayr, {Christian Reinhard} and Tobias Kiesslich and S Erber and Dino Bekric and Heidemarie Dobias and Markus Ritter and Tarkan J{\"a}ger and Neumayer and Eckhard Klieser and Daniel Neureiter",

year = "2021",

language = "Undefined/Unknown",

note = "Cholangiocarcinoma Foundation (CCF) Annual Conference 2021 ; Conference date: 31-03-2021 Through 02-04-2021",

}

TY - CONF

T1 - HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

AU - Mayr, Christian Reinhard

AU - Kiesslich, Tobias

AU - Erber, S

AU - Bekric, Dino

AU - Dobias, Heidemarie

AU - Ritter, Markus

AU - Jäger, Tarkan

AU - Neumayer, null

AU - Klieser, Eckhard

AU - Neureiter, Daniel

PY - 2021

Y1 - 2021

M3 - Poster

T2 - Cholangiocarcinoma Foundation (CCF) Annual Conference 2021

Y2 - 31 March 2021 through 2 April 2021

ER -

HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

Konferenz mit wissenschaftlichem Inhalt

Publikationen

HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

Dieses zitieren